Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial

被引：0
|
作者：
Pudipeddi, A. [1 ,2 ,3 ]
Lin, H. [4 ]
Paramsothy, S. [1 ,3 ]
Kariyawasam, V [1 ,5 ]
Paramsothy, R. [6 ]
Ghaly, S. [7 ,8 ]
Haifer, C. [7 ,8 ]
An, Y. K. [9 ,10 ]
Begun, J. [9 ,10 ]
Connor, S. [11 ,12 ]
Corte, C. [13 ]
Ward, M. [14 ]
De Cruz, P. [15 ,16 ]
Fung, C. [17 ]
Redmond, D. [1 ]
Chan, W. [18 ]
Mourad, F. [19 ]
Kermeen, M. [1 ]
Leong, R. [1 ,3 ,5 ]
机构：
[1] Concord Repatriat Gen Hosp, Gastroenterol & Liver Serv, Sydney, Australia
[2] Australian Natl Univ, Coll Med & Hlth, Sydney, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney, Australia
[4] Tan Tock Seng Hosp, Gastroenterol & Hepatol, Singapore City, Singapore
[5] Macquarie Univ, Fac Med & Hlth Sci, Sydney, Australia
[6] Univ Sydney, Fac Med & Hlth, Sydney, Australia
[7] St Vincents Hosp, Gastroenterol & Hepatol, Sydney, Australia
[8] Univ New South Wales, Sch Clin Med, St Vincents Healthcare Campus, Sydney, Australia
[9] Mater Hosp, Dept Gastroenterol, Brisbane, Australia
[10] Univ Queensland, Mater Res Inst, Brisbane, Australia
[11] Liverpool Hosp, Dept Gastroenterol, Sydney, Australia
[12] Univ New South Wales, UNSW Med & Hlth, South West Sydney Clin Campuses, Sydney, Australia
[13] Royal Prince Alfred Hosp, AW Morrow Gastroenterol Ctr, Sydney, Australia
[14] Alfred Hosp, Dept Gastroenterol, Melbourne, Australia
[15] Austin Hosp, Dept Gastroenterol, Melbourne, Australia
[16] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Australia
[17] Concord Repatriat Gen Hosp, Dept Anat Pathol, Sydney, Australia
[18] Singapore Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
[19] American Univ, Beirut Med Ctr, Gastroenterol, Beirut, Lebanon
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0928
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0754
引用
收藏
页码：I1453 / I1454
页数：2
相关论文
共 26 条
  • [21] Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
    Gregg, Edward W.
    Jakicic, John M.
    Lewis, Cora E.
    Regensteiner, Judith G.
    Pi-Sunyer, Xavier
    Wing, Rena R.
    Curtis, Jeffrey M.
    Yanovski, Susan Z.
    Evans, Mary
    Lang, Wei
    Neiberg, Rebecca H.
    Ribisl, Paul M.
    Gregg, Edward W.
    Jakicic, John M.
    Blackburn, George
    Bloomquist, Paul
    Bray, George A.
    Clark, Jeanne M.
    Coday, Mace
    Curtis, Jeff Rey M.
    Egan, Caitlin
    Evans, Mary
    Foreyt, John P.
    Foster, Gary D.
    Hazuda, Helen P.
    Hill, James O.
    Horton, Edward S.
    Hubbard, Van S.
    Ery, Robert W. Jeff
    Johnson, Karen C.
    Abbas
    Kitabchi
    Knowler, William C.
    Kriska, Andrea
    Lang, Wei
    Lewis, Cora E.
    Montez, Maria G.
    Nathan, David M.
    Neiberg, Rebecca H.
    Patricio, Jennifer
    Peters, Anne
    Pi-Sunyer, Xavier
    Pownall, Henry
    Redmon, Bruce
    Regensteiner, Judith G.
    Rejeski, W. Jack
    Ribisl, Paul M.
    Ord, Monika Saff
    Stewart, Kerry
    Trence, Dace
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (11): : 913 - 921
  • [22] Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label multicentre, randomised, phase 3 trial
    Zoellner, Anna-Katharina
    Unterhalt, Michael
    Stilgenbauer, Stephan
    Huebel, Kai
    Thieblemont, Catherine
    Metzner, Bernd
    Topp, Max
    Truemper, Lorenz
    Schmidt, Christian
    Bouabdallah, Kamal
    Krauter, Juergen
    Lenz, Georg
    Duerig, Jan
    Vergote, Vibeke
    Schaefer-Eckart, Kerstin
    Andre, Marc
    Kluin-Nelemans, Hanneke C.
    van Hoof, Achiel
    Klapper, Wolfram
    Hiddemann, Wolfgang
    Dreyling, Martin
    Hoster, Eva
    LANCET HAEMATOLOGY, 2021, 8 (09): : E648 - E657
  • [23] Sex-Related Differences in the Long-Term Outcomes of Patients with Femoropopliteal Arterial Disease Treated with the IN.PACT Drug-Coated Balloon in the IN.PACT SFA Randomized Controlled Trial: A Post Hoc Analysis
    Kohi, Maureen P.
    Brodmann, Marianne
    Zeller, Thomas
    Micari, Antonio
    Baumgartner, Iris
    Wang, Hong
    Wall, Bridget
    Razavi, Mahmood K.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (09) : 1410 - +
  • [24] Response to: 'Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al' by Bettiol et al
    Chatzidionysiou, Katerina
    Samoli, Evangelia
    Sfikakis, Petros P.
    Tektonidou, Maria G.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
  • [25] Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study
    Carlsson, Lena M. S.
    Sjoholm, Kajsa
    Karlsson, Cecilia
    Jacobson, Peter
    Andersson-Assarsson, Johanna C.
    Svensson, Per-Arne
    Larsson, Ingrid
    Hjorth, Stephan
    Neovius, Martin
    Taube, Magdalena
    Carlsson, Bjorn
    Peltonen, Markku
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (04): : 271 - 279
  • [26] Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the random-ised, placebo-controlled, phase 3 trial (vol 19, pg 998, 2020)
    Wolinsky, J. S.
    Arnold, D. L.
    Brochet, B.
    LANCET NEUROLOGY, 2021, 20 (01): : E1 - E1
123